相似文献/References:
[1]杨新林,李月春,李锐铭,等.脑血管储备功能的临床应用进展[J].卒中与神经疾病杂志,2015,22(01):50.
[2]王本孝.脑微出血的研究进展[J].卒中与神经疾病杂志,2015,22(01):52.
[3]曹阳月,朱雨岚.脑缺血后处理与PI3K/Akt信号转导通路的研究进展[J].卒中与神经疾病杂志,2015,22(03):192.
[4]解晓睿,刘煜敏,和珂莉,等.中国人群脂联素+45位点基因单核苷酸多态性与缺血性脑卒中易感性的Meta分析[J].卒中与神经疾病杂志,2014,21(06):361.
[5]冯庆琪,李昂,王巍.κ阿片受体激动剂（U50488H）对缺血性脑卒中大鼠神经元自噬、迟发性神经元损伤及NOTCH表达水平的影响[J].卒中与神经疾病杂志,2022,29(04):311.[doi:10.3969/j.issn.1007-0478.2022.04.002]
Feng Qingqi*,Li Ang*,Wang Wei.*.Effects of κ opioid receptor agonist(U50488H)on autophagy, delayed nerve injury and NOTCH expression in ischemic stroke rats[J].Stroke and Nervous Diseases,2022,29(01):311.[doi:10.3969/j.issn.1007-0478.2022.04.002]
[6]曹炳华,乔振虎.缺血性脑卒中患者血清SIRT1水平与早期神经功能恶化的相关性研究[J].卒中与神经疾病杂志,2022,29(04):330.[doi:10.3969/j.issn.1007-0478.2022.04.005]
Cao Binghua,Qiao Zhenhu..Correlation between serum SIRT1 and early neurological deterioration of patients with ischemic stroke[J].Stroke and Nervous Diseases,2022,29(01):330.[doi:10.3969/j.issn.1007-0478.2022.04.005]
[7]何妮,易兴阳.CYP2C8,GPIIIa和P2Y12变异体之间的相互作用增加了缺血性脑卒中的易感性[J].卒中与神经疾病杂志,2022,29(04):359.[doi:10.3969/j.issn.1007-0478.2022.04.011]
[8]何涛,索志超,孔德强,等.术前血清CTRP3,CTRP9水平与缺血性脑卒中患者颈动脉支架成形术后再狭窄的相关性研究[J].卒中与神经疾病杂志,2022,29(05):427.[doi:10.3969/j.issn.1007-0478.2022.05.006]
e Tao*,Suo Zhichao,Kong Deqiang*,et al.Correlation between preoperative serum CTRP3, CTRP9 levels and restenosis after carotid artery stenting in patients with cerebral ischemic stroke[J].Stroke and Nervous Diseases,2022,29(01):427.[doi:10.3969/j.issn.1007-0478.2022.05.006]
[9]林夏妃,吴海霞,史静琴,等.呼吸肌训练经皮质-膈肌通路对缺血性脑卒中患者的作用机制分析[J].卒中与神经疾病杂志,2022,29(05):442.[doi:10.3969/j.issn.1007-0478.2022.05.009]
Lin Xiafei,Wu Haixia,Shi Jingqin,et al.Mechanism of respiratory muscle training via cortical diaphragm pathway in patients with ischemic stroke[J].Stroke and Nervous Diseases,2022,29(01):442.[doi:10.3969/j.issn.1007-0478.2022.05.009]
[10]宋秀威 杨月君 王伟.五味子乙素调节MAPK/NF-κB/AP-1信号通路对缺血性脑卒中大鼠神经元损伤的影响[J].卒中与神经疾病杂志,2023,30(03):242.[doi:10.3969/j.issn.1007-0478.2023.03.002]
Song Xiuwei*,Yang Yuejun,Wang Wei..Schisandrin B attenuates neuronal damage in rats with ischemic stroke by regulating MAPK/NF-κB/AP-1 signaling pathway[J].Stroke and Nervous Diseases,2023,30(01):242.[doi:10.3969/j.issn.1007-0478.2023.03.002]